Cancellation of state registration. Laticort®

November 20, 2017
Active substances:
Trade names:
ICD-10:
XII.L20-L30.L20.8    Other atopic dermatitis
XII.L20-L30.L21    Seborrheic dermatitis
XII.L20-L30.L23    Allergic contact dermatitis
XII.L20-L30.L24    Simple irritant contact dermatitis
XII.L20-L30.L28.0    Simple chronic lichen
XII.L20-L30.L30.0    Coin-like eczema
XII.L40-L45.L40    Psoriasis
XII.L40-L45.L43    Lichen red flat
XII.L50-L54.L53    Other erythematous conditions
Laticort, lichen, lichen treatment, atopic dermatitis, eczema treatment, psoriasis

Ministry of HealthThe Russian Federation, in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On circulation of medicines", decided to abolish state registration and exclude from the state register of medicinal products for the medical use of the medicinal product (registration certificate No. N012869 / 01 of 16.09 .2009 issued by LLC "VALEANT", Russia):

Laticort® (trade name of the medicinal product)

Hydrocortisone (international non-proprietary or grouping or chemical name)

solution for external use, 0.1% (dosage form, dosage)

Pharmaceutical plant Elfa AO, Poland ul. Wincentego Pola 21, 58-500 Jelenia Gora, Poland (name and address of the location of the manufacturer of the medicinal product)

on the basis of the filing of an application for the abolition of the state registration of a medicinal product by the authorized legal entity LLC "VALEANT", Russia.